Biomarin | search
Click here to view Biomarin news from 60+ newspapers.
Bookmark or Share- BioMarin Pharmaceutical Inc.BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.
- BioMarin Pharmaceutical - WikipediaBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs).
- About Us | BioMarinBioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Our Purpose.
- Our Science | BioMarinAt BioMarin, we’re committed to delivering on the promise of genetic discoveries by translating them into transformative medicines. To achieve this, we: Leverage genetic discoveries and tools to ensure a clear understanding of the underlying mechanisms of disease.
- US FDA approves BioMarin's gene therapy for hemophilia AJune 29 (Reuters) - The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's (BMRN.O) gene therapy for severe hemophilia A, the company said, giving patients with the...
More
